news A vaccine against placental malaria made with ExpreS2ion Biotechnologies’ protein expression technology, ExpreS2, is ready to start human tests in Germany and Benin 20 March 2015 | By Victoria White ExpreS2ion Biotechnologies announce the release by its partners at University of Copenhagen of a vaccine against placental malaria for testing in humans...
news Targeted therapies offer novel treatment modalities for breast cancer 19 March 2015 | By Victoria White While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted therapies is on the rise...
news MISSION Therapeutics appoints Paul Wallace as Chief Business Officer 19 March 2015 | By Victoria White MISSION Therapeutics announces the appointment of Paul Wallace PhD as Chief Business Officer...
news First treatment approved under EAMS developed using antibody humanization expertise at UK’s MRC Technology 11 March 2015 | By MRC Technology New breakthrough immunotherapy (pembrolizumab) launched in the UK for treatment of adults with advanced melanoma...
news Phico Therapeutics receives Translation Award to advance its SASPject™ PT4 aimed at Escherichia coli and Klebsiella pneumoniae towards clinical trials 9 March 2015 | By Phico Therapeutics Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a £2.25M Translation Award by the Wellcome Trust to develop its SASPject™ PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumoniae...
news University spin-out gets crowdfunding investment to develop a cure for Parkinson’s Disease 9 March 2015 | By Edinburgh Research and Innovation University of Edinburgh spin-out company Parkure Ltd has successfully attracted over £75,000 in crowdfunding investment through ShareIn, the technology-focussed crowdfunding firm, to develop a cure for Parkinson’s disease...
news MRC Technology launches respiratory ‘Call for Targets’ 2 March 2015 | By MRC Technology Project focused on potential small molecule or antibody targets in pathways important in the development or progression of respiratory disease...
news Registration is open for the 3rd Annual Discovery Chemistry & Drug Design in Berlin, 8th & 9th June 2015 25 February 2015 | By Oxford Global Oxford Global are proud to present its 3rd Annual Discovery Chemistry & Drug Design will be on the 8th and 9th of June 2015...
news Registration is open for the 16th Annual Drug Discovery Summit in Berlin, 8th & 9th June 2015 25 February 2015 | By Oxford Global Oxford Global are proud to present its 16th Annual Drug Discovery Congress will be on the 8th and 9th of June 2015...
news Leading dementia charity launches three Drug Discovery Institutes 18 February 2015 | By Alzheimer’s Research UK Institutes at Universities of Cambridge, Oxford and UCL will form £30m Drug Discovery Alliance...
news SensiQ Technologies and Inventiva set up a European Center of Excellence in surface plasmon resonance (SPR) technologies 9 February 2015 | By SensiQ Technologies/Inventiva Based in Dijon, France, the Center will boast a unique offering for drug discovery in Europe, combining Inventiva’s screening platforms and libraries with SensiQ’s instrumentation...
news Two major studies strengthen case for prostate cancer drug before chemotherapy 5 February 2015 | By The Institute of Cancer Research Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown...
news Rigontec GmbH Appoints Dr. Christian Schetter as CEO 5 February 2015 | By Rigontec GmbH Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, announces the appointment of Dr. Christian Schetter as CEO...
news Major study links two new genetic variants to breast cancer 5 February 2015 | By The Institute of Cancer Research A worldwide study of the DNA of 100,000 women has discovered two new genetic variants associated with an increased risk of breast cancer...
news Oncologic imaging innovation is enabling earlier detection of cancers 4 February 2015 | By Frost & Sullivan Ongoing research aims to develop oncologic imaging technologies that diagnose cancer at the cellular level before the disease manifests, finds Frost & Sullivan...
